Restless leg syndrome (RLS) does not seem like a serious health problem. Compared to coronary heart disease, diabetes or cancer, RLS just doesn’t sound scary. But ask someone with this condition how ...

Restless legs syndrome: a new practice guideline Evidence shows strong support for prescribing pramipexole, rotigotine, cabergoline, or gabapentin enacarbil to treat adults with restless legs syndrome ...

Meredith is an 86-year-old woman who is referred to a sleep medicine specialist for further treatment of refractory restless legs syndrome (RLS). Meredith describes "electric currents" or "shocklike ...

We treat restless legs syndrome with Parkinson’s drugs, such as pramipexole (Mirapex). Will these drugs remain effective for treating Parkinson’s should the patients develop that condition later in ...

Jean Smith, whose name has been changed to protect her privacy, began to experience symptoms of what she later learned was restless legs syndrome (RLS) when she was 29 years old and pregnant. She ...

DARIEN, IL - A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects ...

As the COVID-19 pandemic continues to spread, new and unusual chronic sequelae of the disease are cropping up in many medical practices. Now, a new case paper published in The Lancet in September 2020 ...

Pramipexole dihydrochloride extended-release 0.375mg, 0.75mg, 1.5mg, 2.25mg, 3mg, 3.75mg, 4.5mg; tabs. Swallow whole. May take with food. Initially 0.375mg once daily ...

Compulsive gambling has again been identified as a drug side effect. First, a treatment for Parkinson’s disease was linked to compulsive gambling in 2005. Now, the same family of drugs — dopamine ...

Alembic is launching pramipexole dihydrochloride extended-release tablets. The medication is the generic of Boehringer Ingelheim's Mirapex. It is indicated for the treatment of Parkinson’s disease.

The study shows restless legs syndrome is associated with higher Parkinson's disease incidence, raising questions about treatment impacts on symptoms.